| May Min, MD | |
|
950 Warren Ave Ste 301, East Providence, RI 02914-1432 | |
| (401) 606-4260 | |
| Not Available |
| Full Name | May Min |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 9 Years |
| Location | 950 Warren Ave Ste 301, East Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063807717 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | LP04663 (Rhode Island) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | MD18601 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rhode Island Hospital | Providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lifespan Physician Group Inc | 2567455082 | 631 |
| Rhode Island Hospital | 8921900044 | 303 |
News Archive
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
"Large swaths of the United States are showing decreasing or stagnating life expectancy even as the nation's overall longevity trend has continued upwards, according to a county-by-county study of life expectancy over two decades," researchers at the Institute of Health Metrics and Evaluation (IHME) at the University of Washington note in the journal Population Health Metrics, the Washington Post reports (Brown, 6/15).
Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics' NextGENe software for next-generation sequencing projects performed at Ambry.
Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive "tracer" molecules that bind to and "light up" tau tangles, a protein associated with a number of neurodegenerative diseases including Alzheimer's disease and other related dementias.
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
› Verified 8 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
"Large swaths of the United States are showing decreasing or stagnating life expectancy even as the nation's overall longevity trend has continued upwards, according to a county-by-county study of life expectancy over two decades," researchers at the Institute of Health Metrics and Evaluation (IHME) at the University of Washington note in the journal Population Health Metrics, the Washington Post reports (Brown, 6/15).
Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics' NextGENe software for next-generation sequencing projects performed at Ambry.
Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive "tracer" molecules that bind to and "light up" tau tangles, a protein associated with a number of neurodegenerative diseases including Alzheimer's disease and other related dementias.
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
› Verified 8 days ago
| Entity Name | Rhode Island Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154537520 PECOS PAC ID: 8921900044 Enrollment ID: O20141017000105 |
News Archive
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
"Large swaths of the United States are showing decreasing or stagnating life expectancy even as the nation's overall longevity trend has continued upwards, according to a county-by-county study of life expectancy over two decades," researchers at the Institute of Health Metrics and Evaluation (IHME) at the University of Washington note in the journal Population Health Metrics, the Washington Post reports (Brown, 6/15).
Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics' NextGENe software for next-generation sequencing projects performed at Ambry.
Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive "tracer" molecules that bind to and "light up" tau tangles, a protein associated with a number of neurodegenerative diseases including Alzheimer's disease and other related dementias.
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| May Min, MD 950 Warren Ave Ste 301, East Providence, RI 02914-1432 Ph: (401) 606-4260 | May Min, MD 950 Warren Ave Ste 301, East Providence, RI 02914-1432 Ph: (401) 606-4260 |
News Archive
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
"Large swaths of the United States are showing decreasing or stagnating life expectancy even as the nation's overall longevity trend has continued upwards, according to a county-by-county study of life expectancy over two decades," researchers at the Institute of Health Metrics and Evaluation (IHME) at the University of Washington note in the journal Population Health Metrics, the Washington Post reports (Brown, 6/15).
Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics' NextGENe software for next-generation sequencing projects performed at Ambry.
Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive "tracer" molecules that bind to and "light up" tau tangles, a protein associated with a number of neurodegenerative diseases including Alzheimer's disease and other related dementias.
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
› Verified 8 days ago
Matthew J Franco, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 900 Warren Ave, Suite 401, East Providence, RI 02914 Phone: 800-508-4908 Fax: 401-228-6236 | |
Mr. Michael F Gilson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave, 2nd Floor, East Providence, RI 02914 Phone: 401-606-1004 Fax: 401-606-1153 | |
Dr. Christopher Song, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave, East Providence, RI 02914 Phone: 401-606-1004 Fax: 401-606-1153 | |
Dr. Ricardo Rafael Correa Marquez, M.D Gastroenterology Medicare: Medicare Enrolled Practice Location: 900 Warren Avenue, Suite 300, East Providence, RI 02914 Phone: 786-246-5719 | |
Prerna Ganjoo, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 318 Waterman Ave, East Providence, RI 02914 Phone: 401-438-5950 Fax: 401-435-6700 | |
Mordecai Jeremiah Stolk, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 318 Waterman Ave, East Providence, RI 02914 Phone: 401-438-5950 Fax: 401-435-6700 |